The information highlighted (if any) are the most recent updates for this brand.
LEQEMBI is contraindicated in patients with serious hypersensitivity to lecanemab or to any of the excipients of LEQEMBI. Reactions have included angioedema and anaphylaxis [see Hypersensitivity Reactions under Precautions].